Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 11;11(10):1614.
doi: 10.3390/cells11101614.

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?

Marco Audisio  1 , Consuelo Buttigliero  1 , Fabio Turco  1 , Marco Donatello Delcuratolo  1 , Chiara Pisano  1 , Elena Parlagreco  1 , Rosario Francesco Di Stefano  1 , Lavinia Di Prima  1 , Veronica Crespi  1 , Giovanni Farinea  1 , Massimiliano Cani  1 , Marcello Tucci  2
Affiliations
Editorial

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?

Marco Audisio et al. Cells. .

Abstract

Urothelial cancer is a lethal malignancy characterized by a wide diffusion in Western countries due to a larger exposure to known risk factors, such as aromatic amines, tobacco smoke and benzene [...].

Keywords: FGFR inhibitors; enfortumab vedotin; immunotherapy; urothelial cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Ferlay J., Colombet M., Soerjomataram I., Parkin D.M., Piñeros M., Znaor A., Bray F. Cancer statistics for the year 2020: An overview. Int. J. Cancer. 2021;149:778–789. doi: 10.1002/ijc.33588. - DOI - PubMed
    1. Carlos S., Abdeljalil O.S.S. Metastatic Urothelial Cancer: A rapidly changing treatment landscape. Ther. Adv. Med. Oncol. 2021;13:1–18. doi: 10.1177/17588359211047352. - DOI - PMC - PubMed
    1. Audisio A., Buttigliero C., Delcuratolo M.D., Parlagreco E., Audisio M., Ungaro A., Di Stefano R.F., Di Prima L., Turco F., Tucci M. New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond. Cells. 2022;11:357. doi: 10.3390/cells11030357. - DOI - PMC - PubMed
    1. Lenis A.T., Lec P.M., Chamie K., Mshs M.D. Bladder cancer a review. JAMA-J. Am. Med. Assoc. 2020;324:1980–1991. doi: 10.1001/jama.2020.17598. - DOI - PubMed
    1. Grossman H.B., Natale R.B., Tangen M., Speights V.O., Vogelzang N.J., Trump D.L., deVere White R.W., Sarosdy M.F., Wood D.P., Jr., Raghavan D., et al. Neoadjuvant Chemotherapy Plus Cystectomy Compared With Cystectomy Alone for Locally Advanced Bladder Cancer. N. Engl. J. Med. 2003;349:859–866. doi: 10.1056/NEJMoa022148. - DOI - PubMed

Publication types

MeSH terms

Grants and funding

This research received no external funding.